Finding a Trial
The purpose of a clinical trial is to identify the most effective, safest treatment for a disease. Clinical trials are key steps in the U.S. Food and Drug Administration’s drug approval process. Participants can access cutting-edge therapies while playing a vital role in helping researchers develop new treatments.
Use the FARE Clinical Trial Finder to simplify your search for research studies that fit your needs:
- Fill out the filter menu below. Use keywords for a narrow search, or leave keywords blank for a broader search.
- Click the Search Trials button. Matching trial summaries will appear at right. Select LEARN MORE to view details.
- For more information, email or phone the site coordinator at the trial site nearest to you.
- We strongly recommend that you consult with your healthcare provider about any trials that interest you and refer to our terms of service below.
FARE Clinical Trial Finder searches studies listed on clinicaltrials.gov, a service of the U.S. National Institutes of Health that provides information on publicly and privately supported human clinical studies in all 50 states plus Washington, D.C., and in more than 190 countries and U.S. territories.
All food allergy patients who can give informed consent themselves, or through a legal representative, are eligible to join the FARE Patient Registry. This U.S. focused research study invites patients to complete a series of surveys, sharing their de-identified (anonymous) food allergy experiences with the research community, helping to advance understanding of the disease. All data is stored and maintained in a secure, password-protected database, assuring the privacy, security and confidentiality of all personal information. Learn more and register today to help drive research forward.
Acceptability and Tolerance Study of an Amino Acid Formula With HMOs
To evaluate the acceptability (including gastrointestinal tolerance and compliance) of a hypoallergenic amino acid infant formula with HMOs for the dietary management of cows' milk allergy in infants less than 12 months of age.
Acutelines: a Large Data-/Biobank of Acute and Emergency Medicine
Research in acute care faces many challenges, including enrollment challenges, legal limitations in data sharing, limited funding, and lack of singular ownership of the domain of acute care. To overcome some of these challenges, the Center of Acute Care of the University Medical Center Groningen in the Netherlands, has established a de novo data-, image- and biobank named "Acutelines". Acutelines is initiated to improve recognition and treatment of acute diseases and obtain insight in the consequences of acute diseases, including factors predicting its outcome. Thereby, Acutelines contributes to development of personalized treatment...
Advanced Multimodal Wireless Vital Signs Monitoring for Patients With Asthma and Anaphylaxis
The primary objective of this study is to assess the function and reliability of a non-invasive, skin-like electronic sensor. We hypothesize that this skin sensor will address an unmet need to wirelessly, noninvasively, and rapidly assess critical vital signs and other measures essential to healthcare monitoring for patients with asthma and anaphylaxis.
A Food Additive Removal Diet for Pediatric Eosinophilic Esophagitis
Prospective, pragmatic standard of care clinical trial comparing dietary therapies of standard dairy elimination diet alone (DED) to dairy elimination plus food additive elimination (FREE)
A Hypoallergenicity Study on a New Rice-Based Hydrolysate Formula
Cow's Milk Allergy (CMA) affects between 2-3% of young children but its severity varies between regions/countries. While the long-term prognosis for CMA is good, with the majority (80-90%) of children outgrowing their allergy by around 3-5 years. Breast feeding is the most optimal form of feeding for all infants, regardless of their condition, and in those with CMA maternal dairy exclusion is recommended as first line treatment. In non-breast fed or mixed feeding, a hypoallergenic milk substitute is recommended for young infants. The AAP and other societies such as EAACI and ESPGHAN considers a formula to be 'hypoallergenic' if at least ...
Allergy to Almond in Children
Allergy to tree nuts are frequent in children but allergy to almond is one of the less described tree nuts allergy. The main objective of our study is to determine diagnostic values of skin prick-tests and specific IgE to almond in a population of children sensitized to almond and challenged in our unit from november 2013 to march 2020.
An Extension Study of AK002 in Patients With Eosinophilic Gastritis and/or Eosinophilic Duodenitis
This is a Phase 2, open-label, extension study to assess the safety and tolerability of AK002, given monthly for up to 26 doses.
An Extension Study of Lirentelimab in Eosinophilic Gastritis and/or Eosinophilic Duodenitis (Formerly Referred to as Eosinophilic Gastroenteritis)
This is a Phase 3, open-label, extension study to assess the long term efficacy and safety of lirentelimab given monthly.
Antihistamines in Eosinophilic Esophagitis
Researchers are assessing the safety and effectiveness of antihistamines in the treatment of eosinophilic esophagitis.
A Phase 1 Study of the Safety and Feasibility of Up-titration With INT301 in Adults With Sensitivity to Peanut.
This is a phase 1, single-center, randomized, double-blind, placebo-controlled study in adult participants with peanut allergy. Participants will be randomized in a 3:1 ratio to receive either an escalating dose of INT301 or placebo. The treatment group will be blinded to the investigator, participants, and the Intrommune study team.